Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Colorcon
US Army
Moodys
Cipla
Citi
Harvard Business School
McKinsey
Express Scripts
Fuji

Generated: January 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202535

« Back to Dashboard

NDA 202535 describes PREPOPIK, which is a drug marketed by Ferring Pharms Inc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge. Additional details are available on the PREPOPIK profile page.

The generic ingredient in PREPOPIK is citric acid; magnesium oxide; sodium picosulfate. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the citric acid; magnesium oxide; sodium picosulfate profile page.
Summary for 202535
Tradename:PREPOPIK
Applicant:Ferring Pharms Inc
Ingredient:citric acid; magnesium oxide; sodium picosulfate
Patents:2
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 202535
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PREPOPIK citric acid; magnesium oxide; sodium picosulfate FOR SOLUTION;ORAL 202535 NDA Ferring Pharmaceuticals Inc. 55566-9300 55566-9300-2 2 PACKET in 1 CARTON (55566-9300-2) > 16.1 g in 1 PACKET (55566-9300-0)
PREPOPIK citric acid; magnesium oxide; sodium picosulfate FOR SOLUTION;ORAL 202535 NDA Ferring Pharmaceuticals Inc. 55566-9700 55566-9700-1 2 PACKET in 1 CARTON (55566-9700-1) > 16.2 g in 1 PACKET (55566-9700-0)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;ORALStrength12GM/PACKET;3.5GM/PACKET;10MG/PACKET
Approval Date:Jul 16, 2012TE:RLD:Yes
Patent:➤ SubscribePatent Expiration:Oct 10, 2028Product Flag?YSubstance Flag?Delist Request?
Patent:➤ SubscribePatent Expiration:Oct 10, 2028Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Queensland Health
Boehringer Ingelheim
Fish and Richardson
Fuji
Cipla
Moodys
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot